Indication
Parathyroid carcinoma with hypercalcemia
Parathyroid carcinoma with hypercalcemia refers to a severe endocrine state arising from a rare, malignant neoplasm of the parathyroid glands that autonomous hypersecretes parathyroid hormone. Read more about Parathyroid carcinoma with hypercalcemia
19 drugs 16 manufacturers
Drugs that treat it
Common Parathyroid carcinoma with hypercalcemia therapies.
CINACALCET HCL
CINACALCET HCL
CINACALCET HCL
CINACALCET HCL
CINACALCET HCL
CINACALCET HCL
CINACALCET HCL
CINACALCET HCL
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonParathyroid carcinoma with hypercalcemia refers to a severe endocrine state arising from a rare, malignant neoplasm of the parathyroid glands that autonomous hypersecretes parathyroid hormone.
This malignancy accounts for a small fraction of primary hyperparathyroidism cases, typically presenting in middle-aged adults without a marked sex predominance.
Pathophysiologically, the tumor drives unrestrained osteoclastic bone resorption and renal calcium reabsorption, resulting in profoundly elevated serum calcium concentrations.
Clinically, affected patients frequently exhibit pronounced constitutional fatigue, cognitive changes, nephrolithiasis, renal dysfunction, and fragile bone disease, with unregulated hypercalcemia representing the predominant source of morbidity and mortality.
- nih.gov
Parathyroid carcinoma with hypercalcemia refers to a severe endocrine state arising from a rare, malignant neoplasm of the parathyroid glands that autonomous hypersecretes parathyroid hormone This malignancy accounts for a small fraction of primary hyperparathyroidism cases, typically presenting in middle-aged adults without a marked sex predominance
- nih.gov
Parathyroid carcinoma with hypercalcemia refers to a severe endocrine state arising from a rare, malignant neoplasm of the parathyroid glands that autonomous hypersecretes parathyroid hormone Pathophysiologically, the tumor drives unrestrained osteoclastic bone resorption and renal calcium reabsorption, resulting in profoundly elevated serum calcium concentrations
- nih.gov
This malignancy accounts for a small fraction of primary hyperparathyroidism cases, typically presenting in middle-aged adults without a marked sex predominance Clinically, affected patients frequently exhibit pronounced constitutional fatigue, cognitive changes, nephrolithiasis, renal dysfunction, and fragile bone disease, with unregulated hypercalcemia representing the predominant source of morbidity and mortality
- cancer.gov
Pathophysiologically, the tumor drives unrestrained osteoclastic bone resorption and renal calcium reabsorption, resulting in profoundly elevated serum calcium concentrations
- columbiasurgery.org
Clinically, affected patients frequently exhibit pronounced constitutional fatigue, cognitive changes, nephrolithiasis, renal dysfunction, and fragile bone disease, with unregulated hypercalcemia representing the predominant source of morbidity and mortality
- medlineplus.gov
Clinically, affected patients frequently exhibit pronounced constitutional fatigue, cognitive changes, nephrolithiasis, renal dysfunction, and fragile bone disease, with unregulated hypercalcemia representing the predominant source of morbidity and mortality
Personalize your experience
Follow Parathyroid carcinoma with hypercalcemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.